Profile and variability of intraocular pressure after the EX-PRESS device implant
Abstract Objective: The EX-PRESS device is a surgical alternative for the treatment of POAG. To describe the IOP behavior before and after the implantation of the EX-PRESS, the pharmacological treatment used in the pre and postoperative period and the complications in the first year of the postoperative period. Methods: A quantitative descriptive study with review of electronic medical records of a private ophthalmological reference hospital in Goiânia (GO) from 2013 to 2018. Sample composed of 8 eyes with POAG subjected to the EX-PRESS implant. We observed the variables: gender, age, operated eye, antiglaucomatous medications used, pre and postoperative intraocular pressure, and possible complications. Results: In the preoperative period, all eyes used antiglaucomatous drops, 75% used 3 or more different classes simultaneously. After 12 months of EX-PRESS, only 12.5% used three or more eye drops and 37.5% did not use any eye drops. On average, IOP varied from 18.63mmHg (SD 9.38) in the preoperative period to 14.50mmHg (SD 4.14) at 12 months postoperatively. Complications were: ocular hypotension, ocular hypertension; thinning of the conjunctival blister, cystic blister obstruction of the EX-PRESS. We resolved all coplications. Conclusion: The efficacy of EX-PRESS in IOP reduction was verified in the study. Concomitantly, there was a considerable decrease in anti-glaucomatous medications, and few associated complications.
Main Authors: | , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Oftalmologia
2019
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802019000600364 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0034-72802019000600364 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0034-728020190006003642019-11-27Profile and variability of intraocular pressure after the EX-PRESS device implantSilva,Rodrigo Egidio daJácomo,Juliana de LimaVilela,Lara RibeiroOliveira,Antônio Wilson Soares deRodrigues,Francisco Wellington Glaucoma drainage implants Glaucoma Intraocular pressure Drug therapy Postoperative complications Prosthesis implantation/methods Abstract Objective: The EX-PRESS device is a surgical alternative for the treatment of POAG. To describe the IOP behavior before and after the implantation of the EX-PRESS, the pharmacological treatment used in the pre and postoperative period and the complications in the first year of the postoperative period. Methods: A quantitative descriptive study with review of electronic medical records of a private ophthalmological reference hospital in Goiânia (GO) from 2013 to 2018. Sample composed of 8 eyes with POAG subjected to the EX-PRESS implant. We observed the variables: gender, age, operated eye, antiglaucomatous medications used, pre and postoperative intraocular pressure, and possible complications. Results: In the preoperative period, all eyes used antiglaucomatous drops, 75% used 3 or more different classes simultaneously. After 12 months of EX-PRESS, only 12.5% used three or more eye drops and 37.5% did not use any eye drops. On average, IOP varied from 18.63mmHg (SD 9.38) in the preoperative period to 14.50mmHg (SD 4.14) at 12 months postoperatively. Complications were: ocular hypotension, ocular hypertension; thinning of the conjunctival blister, cystic blister obstruction of the EX-PRESS. We resolved all coplications. Conclusion: The efficacy of EX-PRESS in IOP reduction was verified in the study. Concomitantly, there was a considerable decrease in anti-glaucomatous medications, and few associated complications.info:eu-repo/semantics/openAccessSociedade Brasileira de OftalmologiaRevista Brasileira de Oftalmologia v.78 n.6 20192019-12-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802019000600364en10.5935/0034-7280.20190162 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Silva,Rodrigo Egidio da Jácomo,Juliana de Lima Vilela,Lara Ribeiro Oliveira,Antônio Wilson Soares de Rodrigues,Francisco Wellington |
spellingShingle |
Silva,Rodrigo Egidio da Jácomo,Juliana de Lima Vilela,Lara Ribeiro Oliveira,Antônio Wilson Soares de Rodrigues,Francisco Wellington Profile and variability of intraocular pressure after the EX-PRESS device implant |
author_facet |
Silva,Rodrigo Egidio da Jácomo,Juliana de Lima Vilela,Lara Ribeiro Oliveira,Antônio Wilson Soares de Rodrigues,Francisco Wellington |
author_sort |
Silva,Rodrigo Egidio da |
title |
Profile and variability of intraocular pressure after the EX-PRESS device implant |
title_short |
Profile and variability of intraocular pressure after the EX-PRESS device implant |
title_full |
Profile and variability of intraocular pressure after the EX-PRESS device implant |
title_fullStr |
Profile and variability of intraocular pressure after the EX-PRESS device implant |
title_full_unstemmed |
Profile and variability of intraocular pressure after the EX-PRESS device implant |
title_sort |
profile and variability of intraocular pressure after the ex-press device implant |
description |
Abstract Objective: The EX-PRESS device is a surgical alternative for the treatment of POAG. To describe the IOP behavior before and after the implantation of the EX-PRESS, the pharmacological treatment used in the pre and postoperative period and the complications in the first year of the postoperative period. Methods: A quantitative descriptive study with review of electronic medical records of a private ophthalmological reference hospital in Goiânia (GO) from 2013 to 2018. Sample composed of 8 eyes with POAG subjected to the EX-PRESS implant. We observed the variables: gender, age, operated eye, antiglaucomatous medications used, pre and postoperative intraocular pressure, and possible complications. Results: In the preoperative period, all eyes used antiglaucomatous drops, 75% used 3 or more different classes simultaneously. After 12 months of EX-PRESS, only 12.5% used three or more eye drops and 37.5% did not use any eye drops. On average, IOP varied from 18.63mmHg (SD 9.38) in the preoperative period to 14.50mmHg (SD 4.14) at 12 months postoperatively. Complications were: ocular hypotension, ocular hypertension; thinning of the conjunctival blister, cystic blister obstruction of the EX-PRESS. We resolved all coplications. Conclusion: The efficacy of EX-PRESS in IOP reduction was verified in the study. Concomitantly, there was a considerable decrease in anti-glaucomatous medications, and few associated complications. |
publisher |
Sociedade Brasileira de Oftalmologia |
publishDate |
2019 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802019000600364 |
work_keys_str_mv |
AT silvarodrigoegidioda profileandvariabilityofintraocularpressureaftertheexpressdeviceimplant AT jacomojulianadelima profileandvariabilityofintraocularpressureaftertheexpressdeviceimplant AT vilelalararibeiro profileandvariabilityofintraocularpressureaftertheexpressdeviceimplant AT oliveiraantoniowilsonsoaresde profileandvariabilityofintraocularpressureaftertheexpressdeviceimplant AT rodriguesfranciscowellington profileandvariabilityofintraocularpressureaftertheexpressdeviceimplant |
_version_ |
1756377511235682304 |